James Collins

James Collins

Director/Board Member chez SENTI BIOSCIENCES, INC.

Fortune : 288 911 $ au 31/03/2024

58 ans
Health Technology
Commercial Services
Consumer Services

Profil

James J.
Collins
is the founder of Cellicon Biotechnologies, Inc. (founded in 2000), Corvium, Inc. (founded in 2009), Synlogic Operating Co., Inc. (founded in 2014), EnBiotix, Inc. (founded in 2012), Senti Sub I, Inc. (founded in 2016), Synlogic, Inc. (founded in 2017), Sherlock Biosciences, Inc. (founded in 2018), and Cellarity Inc. (founded in 2017).
He currently holds the position of Independent Director at Fulcrum Therapeutics, Inc. (since 2017), Independent Director at Orion Biotech Opportunities Corp., Independent Director at Senti Biosciences, Inc. (since 2022), Professor at Harvard University, Professor at Massachusetts Institute of Technology (since 2014), and Member of the National Academy of Sciences, American Academy of Arts & Sciences, National Academy of Engineering, National Academy of Medicine (United States), Excel Medical Ventures LLC (Board of Strategic Advisors), The Broad Institute, Inc., Harvard Mit Health Sciences & Technology, and National Academy of Inventors.
He previously held the position of Chief Scientific Officer at Aitia, Inc. (from 2008 to 2012) and Professor at Boston University (from 1990 to 2014).
He completed his undergraduate degree at the College of the Holy Cross (Massachusetts) and obtained a doctorate degree from the University of Oxford.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
27/06/2023 23 571 ( 0,04% ) 222 510 $ 31/03/2024
16/06/2023 176 130 ( 0,38% ) 66 401 $ 31/03/2024

Postes actifs de James Collins

SociétésPosteDébut
ORION BIOTECH OPPORTUNITIES CORP. Director/Board Member -
FULCRUM THERAPEUTICS, INC. Director/Board Member 01/01/2017
SENTI BIOSCIENCES, INC. Director/Board Member 08/06/2022
Massachusetts Institute of Technology Corporate Officer/Principal 01/12/2014
Corporate Officer/Principal -
Director/Board Member -
Harvard Mit Health Sciences & Technology Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░░ ░░ ░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Tous les postes actifs de James Collins

Anciens postes connus de James Collins

SociétésPosteFin
░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░ -
░░░░░░░░░ ░░░░ ░░░░░░░ -
░░░░░░░░░ ░░░░ ░░░░░░░ -
Voir l'expérience en détail de James Collins

Formation de James Collins

College of the Holy Cross (Massachusetts) Undergraduate Degree
University of Oxford Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de James Collins

Relations

100 +

Relations au 1er degré

25

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
FULCRUM THERAPEUTICS, INC.

Health Technology

SYNLOGIC, INC.

Health Technology

SENTI BIOSCIENCES, INC.

Health Technology

Entreprise privées16

Health Technology

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Finance

Health Technology

Technology Services

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. James Collins